NeoLumina Bioscience Advancing Development of Proprietary Psychedelic-based Therapeutic Medicines einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, today announced an exclusive global licensing agreement with NeoLumina Bioscience Inc. ("NeoLumina"), a company focused on the development and commercialization of novel therapeutics inspired by psychedelics. Under the terms of the agreement, Filament will license its proprietary botanical psilocybin drug candidate, PEX010, and associated intelle